147 related articles for article (PubMed ID: 23412907)
1. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
Khurana A; Jung-Beom D; He X; Kim SH; Busby RC; Lorenzon L; Villa M; Baldi A; Molina J; Goetz MP; Shridhar V
Clin Exp Metastasis; 2013 Apr; 30(4):407-15. PubMed ID: 23412907
[TBL] [Abstract][Full Text] [Related]
2. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
[TBL] [Abstract][Full Text] [Related]
3. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
[TBL] [Abstract][Full Text] [Related]
4. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
[TBL] [Abstract][Full Text] [Related]
5. Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies.
Assefnia S; Dakshanamurthy S; Guidry Auvil JM; Hampel C; Anastasiadis PZ; Kallakury B; Uren A; Foley DW; Brown ML; Shapiro L; Brenner M; Haigh D; Byers SW
Oncotarget; 2014 Mar; 5(6):1458-74. PubMed ID: 24681547
[TBL] [Abstract][Full Text] [Related]
6. Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.
Peterson SM; Iskenderian A; Cook L; Romashko A; Tobin K; Jones M; Norton A; Gómez-Yafal A; Heartlein MW; Concino MF; Liaw L; Martini PG
BMC Cancer; 2010 Aug; 10():427. PubMed ID: 20707913
[TBL] [Abstract][Full Text] [Related]
7. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
8. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
[TBL] [Abstract][Full Text] [Related]
10. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
[TBL] [Abstract][Full Text] [Related]
11. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
[TBL] [Abstract][Full Text] [Related]
12. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer.
Morimoto-Tomita M; Uchimura K; Bistrup A; Lum DH; Egeblad M; Boudreau N; Werb Z; Rosen SD
Neoplasia; 2005 Nov; 7(11):1001-10. PubMed ID: 16331886
[TBL] [Abstract][Full Text] [Related]
13. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
[TBL] [Abstract][Full Text] [Related]
14. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
[TBL] [Abstract][Full Text] [Related]
15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of sulfatase-1 decreases metastatic potential of SKOV3 human ovarian cancer cells
Mahmoud SA; Mohammed MI; Mahmoud MA; Munkaila A; Yabasin IB
J Cancer Res Ther; 2019; 15(6):1288-1295. PubMed ID: 31898662
[TBL] [Abstract][Full Text] [Related]
17. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
[TBL] [Abstract][Full Text] [Related]
18. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
20. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
Lamanna WC; Frese MA; Balleininger M; Dierks T
J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
